Sernova Corp. (OTCMKTS:SEOVF – Get Free Report) saw a large increase in short interest in February. As of February 28th, there was short interest totalling 253,400 shares, an increase of 7,818.8% from the February 13th total of 3,200 shares. Based on an average trading volume of 63,900 shares, the short-interest ratio is presently 4.0 days. Currently, 0.1% of the company’s stock are sold short.
Sernova Stock Performance
Shares of Sernova stock traded up $0.00 during trading on Wednesday, reaching $0.13. The company had a trading volume of 9,041 shares, compared to its average volume of 28,380. Sernova has a fifty-two week low of $0.12 and a fifty-two week high of $0.45. The firm’s fifty day moving average is $0.14 and its 200-day moving average is $0.17. The company has a market cap of $42.70 million, a price-to-earnings ratio of -2.17 and a beta of 1.13.
Sernova (OTCMKTS:SEOVF – Get Free Report) last announced its quarterly earnings data on Monday, December 23rd. The company reported ($0.01) earnings per share (EPS) for the quarter.
About Sernova
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
See Also
- Five stocks we like better than Sernova
- 3 Healthcare Dividend Stocks to Buy
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- How to trade using analyst ratings
- Why Energy Transfer Belongs on Your Watchlist
- Growth Stocks: What They Are, Examples and How to Invest
- Why Wayfair Stock May Be a Hidden Gem for Value Investors
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.